Rodeo Therapeutics Corp.

The biggest question going into the J.P. Morgan Healthcare Conference every year is which big company is going to announce a large acquisition. Amgen, Inc. CEO Robert Bradway’s answer on 11 January

Amgen, Inc. is continuing down its chosen 2021 path of M&A, entering into an agreement to acquire the private US venture Teneobio, Inc. for $900m in cash upfront, plus future contingent milestone p

Who: Amgen/Rodeo Therapeutics What: Amgen agreed to buy privately held Rodeo for $55m and potential earnouts. Why: In its second M&A deal of the year, Amgen acquired a company focused on therapie

A Maryland law prohibiting "price gouging" in the sale of certain off-patent and generic drugs is to go into effect Oct. 1, after a court found the Association for Accessible Medicines had not shown i